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Wewere interested in whether central nervous system
progenitor cells possess the signal transductionmachin-
ery necessary to mediate cytokine functions and
whether this machinery can become activated upon sta-
ble expression of a particular cytokine receptor. For this
purpose we utilized a previously obtained conditionally
immortalized striatum-derived nestin-positive cell line
(ST14A). We found that ST14A cells express Jak2, but not
Jak1 or Tyk2. An identical pattern of expression was
found in embryonic striatal tissue. To evaluate the sus-
ceptibility of these cytokine specific cytoplasmic trans-
ducers to activation, ST14A cells were stably transfected
with the a and b (AIC2A) chains of the murine interleu-
kin-3 receptor. Four independent lines expressing both
the a and b receptor subunits were obtained. We found
that cells from each of these lines were induced to pro-
liferate upon exposure to interleukin-3. Dose response
curve, antibody blocking experiments and binding stud-
ies revealed that the response was mediated by the re-
constituted high affinity interleukin-3 receptor. Immu-
noprecipitation studies on these cells showed that Jak2
and Stat5 were being phosphorylated after stimulation
of the reconstituted receptor. These results indicate
that members of the JAK/STAT family of proteins are
expressed in central nervous system progenitor cells
and are susceptible to activation through stimulation of
an exogenously expressed cytokine receptor, ultimately
leading to cell proliferation.
In the hematopoietic system, early stem cells generate sec-
ondary progenitors which, through successive cell divisions,
give rise to the dazzling array of cell types found in blood (1).
During the development of the nervous system a similar series
of events generates the various neurons and glia constituting
the mature brain (2). In recent years, it has become evident
that the pyramidal hierarchy of cell maturation peculiar to
these two cell systems is controlled by a variety of soluble
molecules (1, 3) and that functionally and/or biochemically
homologous proteins operate in the two systems (4–6).
The idea of a functional and structural link between the
hematopoietic and nervous systems is further supported by the
findings that cytokines and cytokine receptors are expressed in
both the developing and mature mammalian central nervous
system (CNS)1 (7–10). In addition, important biological func-
tions have been uncovered for some of these molecules which
appear to be mainly implicated in driving or maintaining dif-
ferentiated properties in specific subpopulations of postmitotic
neurons (12–14). Nevertheless, the fact that cytokine receptors
are confined to limited subpopulations of differentiated CNS
cells has hampered detailed functional and biochemical analy-
sis of cytokine-elicited responses and signal transduction mech-
anisms activated by these molecules in mature CNS cells and
their progenitors.
Cytokine effects in hematopoietic cells have been more thor-
oughly investigated and have led to the discovery of two fami-
lies of proteins involved in cytokine signal transduction: 1) the
Janus kinase (JAK) proteins, a class of four cytoplasmic tyro-
sine kinases (Tyk2, Jak1, Jak2, and Jak3) and 2) the signal
transducers and activator of transcription (STAT) proteins,
composed by six latent transcription factors (Stat1–6) that
become phosphorylated on tyrosine in response to receptor
activation (for reviews, see Refs. 15 and 16). To date only two
reports are available describing JAK presence in the nervous
system. The first, from Yang et al. (17), reports the cloning of
Jak1 from mouse brain and provides evidence for the presence
of Jak1 mRNA in retina and total brain during development,
and for expression of the protein in limited groups of cells in the
adult CNS. In the second, by using PCR cloning techniques
Sanchez et al. (18) isolated tyrosine kinase sequences from
embryonic hippocampal neurons. Among the amplified se-
quences the authors found Jak1, Jak2, and Jak3.
Prompted by these observations we first investigated
whether Jak1, Jak2, or Tyk2 proteins were expressed in em-
bryonic CNS progenitors and whether this pathway could be-
come activated once stable expression of particular cytokine
receptors was achieved. We focussed on the IL3 receptor (IL3R)
as a possible activator of JAK pathways in embryonic CNS
cells, particularly since in vitro production of IL3 by murine
central nervous system neurons (10), expression of its mRNA in
brain areas (9) and IL3R associated antigens (19) have been
reported, indicating that endogenous IL3 might be produced
locally and its corresponding receptors transiently expressed in
vivo by certain neurons or their progenitors.
Conditionally immortalized ST14A cells previously obtained
by retroviral transduction of the temperature-sensitive
(tsA58U19) allele of the large T-antigene oncogene into pri-
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mary striatal cells (20) were thus utilized in experiments aimed
at expressing the a and b (AIC2A) subunits of the murine IL3R
(for a review on the biochemistry and molecular biology of this
receptor system, see Ref. 21).
In this study, we showed that Jak2 is expressed in vivo in the
CNS at early developmental stages, as well as in vitro in the
immortalized CNS progenitors. We found that in these cells
Jak2, as well as Stat5, become phosphorylated on stimulation
of the reconstituted high affinity IL3R by IL3. The triggered
cells were undergoing cell division in serum free conditions.
This effect was found to be strictly dependent on the presence
of the cytokine.
EXPERIMENTAL PROCEDURES
Cell Culture—ST14A cell line was previously obtained from primary
cells dissociated from E14 striatum primordia and immortalized using
a retrovirally transduced temperature-sensitive variant (tsA58U19) of
SV40 Large T-antigen (20).2 ST14A cells were found to express nestin,
a cytoskeletal antigen specifically present in CNS progenitors (22). The
cells were propagated routinely at 33 °C in Dulbecco’s modified Eagle’s
medium (Life Technologies, Inc.) supplemented with 0.11 g/liter sodium
pyruvate, 3.7 g/liter NaHCO3, 0.29 g/liter glutamine, 3.9 g/liter HEPES,
100 units/ml penicillin-streptomycin (Life Technologies, Inc.), and 10%
fetal calf serum (Imperial, UK).
Plasmids and Transfection Experiments—The cDNAs coding for the
a (SUT-1) and bIL3 (AIC2A) subunits of the murine IL3 receptor were
cloned into the polylinker of the pLXSP expression vector (gift from J.
F. Lacoud) conferring resistance to puromycin and giving rise to the
plasmids, pLXSPaIL3R and pLXSPbIL3R. Standard transfections were
performed with the CaPO4 kit (Stratagene, Life Technologies, Inc.). In
each transfection experiment, 5 mg of each plasmid DNA were utilized.
Following transfection, cells were rinsed free of the precipitate, and
puromycin at 3 mg/ml was applied after a further 48 h. Resistant
colonies were transferred into 24-well dishes, incubated, and cryopre-
served. Of the puromycin-resistant clones, four expressed both of the
IL3R subunits. These clones were named ab14, ab20, ab28, and ab29.
RNase Protection Assay—The assay was performed as described (23).
Fifteen mg of total RNA were hybridized to 32P-labeled antisense RNA
probes at 52 °C overnight and then treated with RNase A and T1. The
reaction products were loaded onto a 6% polyacrylamide sequencing gel.
The bIL3R probe and the aIL3R probe were as described by Liboi et al.
(23, 24).
[3H]Thymidine Incorporation and Proliferation Assays—DNA syn-
thesis was measured by [3H]thymidine incorporation. Briefly, 2.5 3 104
cells were exposed to serum-free medium (SFM, composition: 1:1 F12:
Dulbecco’s modified Eagle’s medium including 5 mg/ml insulin, 100
mg/ml transferrin, 20 nM progesterone, 30 nM selenium salt, 60 mM
putrescine, 2 mM glutamine, 0.11 mg/ml sodium bicarbonate, 4.3 mg/ml
HEPES buffer) for 16 h prior to starting the experiment, markedly
reducing the ability of ST14A cells to proliferate compared to when
serum was present (20). Recombinant murine IL3 (rmIL3) (Biosource
International, Celbio, Italy) at 2 ng/ml was applied for the time indi-
cated under “Results.”
Tritiated thymidine, 1 mCi/ml of medium (specific activity, 2 mCi/
mmol; Amersham Corp.) was added for 6 h before harvesting the cells.
Rinsed cultures were solubilized in NaOH and aliquots assayed for
radioactivity by addition of scintillation liquid and for protein by stand-
ard protein assays (Bradford). When this experiment was performed in
cells exposed to 39 °C, [3H]thymidine of higher specific activity (87
Ci/mmol; Amersham Corp.) was used. For the proliferation assay, cells
from transfected clones were seeded at a density of 3 3 104 cells into
each well of a six-well dish and incubated for 16 h in SFM. After 16 h
(time 0), rmIL3 was added to the treated plates. The cells were then
counted by Coulter Counter (model ZM from Coulter Instruments,
Milan, Italy) at 24-h intervals for 7 days (168 h). Live cells were counted
after trypsinization of the monolayers.
Radioiodination of IL3 and Binding Assay—Carrier-free recombi-
nant murine IL3 was iodinated by the iodine monochloride method (25).
Briefly, 5 mg of rmIL3 were incubated in the presence of 2 mCi of NaI
(Amersham Corp.) and 4 mM iodine monochloride (ICl). 125I-IL3 was
separated from free iodine by passage through a Sephadex-G25M col-
umn. Fractions containing the radioactivity were collected, and an
aliquot was examined by SDS-PAGE. The iodinated IL3 was calculated
to have a specific activity of 79.7 cpm/fmol.
For the binding experiments, 3 3 105 cells were incubated with
125I-IL3 for 4 h at 4° C in RPMI containing 30 mM HEPES, 1% bovine
serum albumin, 0.1% NaN3, 0.1 mM bacitracin and 5 mg/ml aprotinin.
A saturation curve was obtained by incubating sets of cells with various
amounts of 125I-IL3 in the range of 0.5 3 103 to 20 3 104 cpm (corre-
sponding to an estimated 0.01–20 nM of IL3). Cells were then washed
several times with phosphate-buffered saline (PBS) containing bovine
serum albumin and lysed. Radioactivity was measured by gamma coun-
ter and normalized over the protein content (Bradford assay). Nonspe-
cific binding was determined in the presence of a fixed excess (1003) of
unlabeled rmIL3 as competitor to the labeled species, and this value
was subtracted from the total binding to yield the specific binding. All
samples were tested in triplicate and used to estimate values of Kd and
Bmax by the LIGAND program.
Immunohistochemistry—Cells were plated onto 12 mm diameter
glass coverslips coated with poly-D-ornithine. For the immunohisto-
chemistry, cultures were fixed for 15 min in 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.4) followed by two rinses in PBS. After
permeabilizing the cells in 0.2% Triton X-100 in PBS, Jak2 antibodies
(polyclonal Transduction Lab, DBA, Italy) were applied at 4 °C for 16 h
followed by a fluorescein-conjugated secondary antibody at a 1:100
dilution (1 h at room temperature; Vector, DBA, Italy). Following re-
moval of the secondary antibody, coverslips were mounted using Per-
mafluor (Italscientifica, Italy).
Immunoprecipitation and Western Blot Analyses—For the immuno-
precipitation experiments 1 3 107 cells from the ab14 line were starved
in serum-free medium for 16 h. Thirty min before treatment, 5 mM
Na3VO4 was added to each plate. The cells were then exposed to murine
recombinant IL3 for 5 or 10 min and subsequently lysed in buffer
containing 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM
dithiothreitol, 5 mM EDTA, 1% Nonidet P-40, 1 mM Na3VO4, 1 mM
ZnCl2, 10 mM NaF, 5 mg/ml aprotinin, 2 mg/ml leupeptin, and 1 mM
phenylmethylsulfonyl fluoride. The lysates were precleared with pro-
tein-A Sepharose (Sigma, Italy) for 30 min at 4 °C and then incubated
in the presence of 4G10 anti-phosphotyrosine monoclonal antibodies
(UBI, DBA-Italy) or with a rat anti-mouse bIL3 chain (anti-AIC2A)
(clone 18H6–14) (26) for 16 h at 4 °C. Immune complexes were precip-
itated with protein A-Sepharose and washed in lyses buffer, and the
eluted proteins were loaded onto 7.5–10% SDS-PAGE column. The
filters were reacted with 4G10 anti-phosphotyrosine (1:1000), anti-Jak2
(1:1000; UBI, DBA, Italy), or anti-Stat5 (1:250; Transduction Lab.;
DBA, Italy) followed by the respective peroxidase conjugated secondary
antibodies and visualized with the ECL detection system (Amersham
Corp.) as described by the manufacturer.
For Western blot analyses, the striatum primordia were dissected
from E14 rat embryos as described previously (27). Membranes of total
cell lysates from ST14A and ab14 cells, as well as those from the
embryonic striatum, were reacted with anti-Jak1 (1:1000; Transduction
Lab.; DBA, Italy), anti-Tyk2 (1:1000; Transduction Lab.; DBA, Italy),
and anti-Jak2 antibodies.
RESULTS
Expression of JAK Proteins in CNS Progenitors in Vivo and
in Vitro—To evaluate whether members of the JAK family
were expressed in CNS progenitors, Western blot analyses
were performed on total lysates from the E14 striatum primor-
dia and from parental ST14A cells. Fig. 1A shows the presence,
in the cell line and embryonic striatal tissue, of a 130-kDa
immunoreactive band in the anti-Jak2-reacted blots. As shown
in the figure, in neither of the two samples could any immuno-
reactivity be detected for either Jak1 or Tyk2. Lysates for
positive controls are shown on the left lane of each blot. Immu-
nocytochemical analysis (Fig. 1B) showed the Jak2 signal lo-
calized in the cytoplasm of ST14A progenitor cells.
Gene Transfer and IL3R mRNA Expression—The pLXSP-
derived vectors containing the a and b (AIC2A) IL3R subunits
were co-transfected into nestin-positive ST14A cells (20). Si-
multaneous expression of the a and b IL3R chains in four
puromycin-resistant clones was evaluated by RNase protection
assay. As shown in Fig. 2, protected bands corresponding to the
a and b IL3R subunits were present in clones ab14, ab20,
ab28, and ab29. In these clones the 127-bp protected fragment
corresponding to the b IL3 (AIC2A) receptor subunit (Fig. 2B2 E. Cattaneo, unpublished results.
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comigrates with the endogenous b IL3R chain expressed in the
Ba/F3 hematopoietic line. Fig. 2A shows the same cell clones
expressing a 72-bp protected fragment that comigrates with
the a IL3R chain present in Ba/F3 cells. No protected bands
were seen when tRNA or RNA from parental ST14A cells were
hybridized with either the a or b riboprobes.
DNA Synthesis in IL3R-transfected Lines—To determine
whether activation of the transfected IL3R could stimulate
DNA synthesis, [3H]thymidine incorporation experiments were
performed. Table I shows the data obtained for the four lines
expressing both subunits of the receptor and for two lines (b11
and a9) expressing only one of the two receptor subunits. It is
evident in Table I that the ab14, ab20, ab28, and ab29 lines
expressing the complete receptor showed increased [3H]thymi-
dine incorporation on stimulation with IL3. Specifically, ab14
cells not given IL3 incorporated 256 6 91 cpm/mg of protein,
while IL3-treated cultures incorporated 514 6 13 cpm/mg of
protein (100% increase over control). In b11 and a19 lines
expressing only the b or the a IL3 receptor subunit, respec-
tively, as well as in parental ST14A cells, exposure to IL3 did
not elicit any effect.
Given that ab14 cells exhibited the greatest biological effect
following IL3 stimulation, this clone was chosen for further
experiments. Increased thymidine incorporation was also ob-
served in IL3-stimulated ab14 cells exposed to 39° C. Indeed,
when exposed to 39° C for 24 h and treated for 24 additional h
with IL3, these cells incorporated 473 6 60 cpm/mg of protein,
while unstimulated cells incorporated significantly less thymi-
dine (211 6 64 cpm/mg of protein; p , 0.001 by Student’s t test).
Binding Assays—Binding experiments were performed on
ab14 cells and in parental ST14A cells. We found saturable
binding in the transfected cells. LIGAND program analysis
indicated a Bmax value of 178 fmol/mg of protein (610%) with
an apparent Kd of 212 pmol/liter for ab14 cells. On the other
hand, ST14A cells showed no specific binding. These results
confirmed the presence of a functional high affinity IL3R on
ab14 CNS progenitor cells. All of the experiments reported
were repeated over more than 1 year, indicating that the trans-
gene was stably integrated.
Dose Response Curve and Antibody Blocking Experi-
ments—We analyzed the effect of different doses of rmIL3 on
the synthesis of DNA in ab14 cells. Fig. 3 shows the linearity of
the effect of IL3 in a range 0.05–2 ng/ml. Importantly, the
concentration of IL3 required to obtain maximal incorporation
of [3H]thymidine (2 ng/ml) correlated well with the receptor Kd,
both being in the picomolar range (28).
Antibody blocking experiments indicated that the effect of
IL3 on DNA synthesis could be partially blocked by preincu-
bating the cells with an antibody against the b receptor subunit
FIG. 1. Expression of the JAK pro-
teins in ST14A cells and E14 striatum
primordia. A, proteins were separated
on 7.5% SDS-PAGE, transferred to nitro-
cellulose, and immunoblotted with anti-
Jak1 (left panel), anti-Jak2 (center panel),
and anti-Tyk2 (right panel). In each
panel, the left column is represented by a
positive control and shows an immunore-
active signal for Jak1 in control Hela
cells, for Jak2 in control A431 cells, and
for Tyk2 in control human fibroblasts. A
band at 130 kDa (molecular mass) is pres-
ent in lysates from either ST14A cells and
cells freshly dissociated from the E14 stri-
atum primordia. B, immunofluorescent
detection of Jak2 in ST14A cells.
FIG. 2. Expression of the a and b IL3R subunits in IL3R trans-
fected CNS progenitor cells. Total RNA from hematopoietic Ba/F3
cells (positive control) and puromycin-resistant ab14, ab20, ab28, and
ab29 clones were analyzed by RNase protection assay. A, aIL3R ribo-
probe protects a 72-bp fragment in the RNAs from the four puromycin-
resistant lines and in Ba/F3 cells. Left lane, free RNA probe. B, bIL3R
(AIC2A) riboprobe protects fragments of 127 bp (AIC2A) in the ab
clones as well as in Ba/F3 cells. In the panel the 90- and 76-bp-protected
fragments visible in control Ba/F3 cells correspond to the endogenous
bcIL3 (AIC2B) chain (23). Negative control tRNA lane and the DNA
molecular weight marker l (BstEII digested) are shown.
Recruitment of Janus Kinases in Dividing CNS Progenitors23376
(26). Thus, cultures treated with both IL3 and the 25C9 block-
ing antibody (10 mg/ml) for 24 h showed a 52% reduction in
thymidine incorporated compared to the cultures treated with
IL3 (IL3 treated: 389 6 40 cpm/mg of protein; IL3 plus blocking
antibody: 297 6 9 cpm/mg of protein; difference, p , 0.001 by
Student’s t test). In the presence of the antibody alone 198 6 20
cpm/mg of protein were incorporated, while control cultures
(without IL3) incorporated 177 6 23 cpm/mg of protein. We
therefore conclude that the observed effects were specifically
driven by the presence of the transfected IL3R.
Growth Curve of IL3-stimulated ab14 Cells—Incorporation
of radioactive thymidine occurs in cells entering a new cell
cycle, but it can also reflect other phenomena such as DNA
repair in damaged cells. To ascertain whether the activated
IL3R mediates a proliferative event in CNS progenitor cells, we
performed growth curve analysis in ab14 cells maintained at
33° C in SFM in the presence or absence of 2 ng/ml rmIL3. As
shown in Fig. 4, a statistically significant increase in the num-
ber of cells occurred in stimulated (broken line) versus unstimu-
lated (solid line) cultures 24 h following treatment. At 72 h,
twice as many cells were present in IL3 treated then untreated
cultures (control cultures: 0.81 3 105 6 0.09 3 105 cells; IL3-
stimulated cultures: 1.63 3 105 6 0.2 3 105 cells). At conflu-
ency (168 h), stimulated cells did not acquire a transformed
phenotype.
Immunoprecipitation Studies—In the hematopoietic system,
activation of the IL3R leads to Jak2 and Stat5 phosphorylation
(29, 30). We showed that Jak2 is expressed in the immortalized
progenitors as well as in the embryonic material from which
the immortalized cells were derived (Fig. 1). We therefore
wanted to determine whether the biological effect observed on
stimulation of the exogenously expressed IL3R occurred
through activation of Jak2 and phosphorylation of Stat5. To
reveal whether Jak2 was recruited by the activated exogenous
receptor, lysates from ab14 cells were subjected to immunopre-
cipitation with the rat anti-b subunit monoclonal antibody and
the membrane filter reacted with the anti-Jak2 antibody. As
shown in Fig. 5A (arrow), the association of Jak2 with the
exogenous b subunit is mainly prompted by the presence of the
ligand. Indeed, an increased quantity of Jak2 protein could be
immunoprecipitated in lysates from cells which had been stim-
ulated with IL3 for 5 min. In a parallel filter immunodecorated
with anti-b subunit antibodies, equal amounts of immunopre-
cipitated b chain were detected in all samples (data not shown).
When the ab14 cell lysates were immunoprecipitated with
the 4G10 anti-phosphotyrosine antibody and immunoblotted
with anti-Jak2 (Fig. 5B), a tyrosine phosphorylated band of 130
kDa corresponding to Jak2 could be detected in lysates from
stimulated cells (arrow). We also wanted to determine whether
Stat5 was as well phosphorylated upon receptor stimulation.
As shown in Fig. 5C, in lysates from stimulated ab14 cells,
which were immunoprecipitated with the 4G10 antibody and
immunoblotted with anti-Stat5 antibodies, a 95–96-kDa reac-
tive band could be detected.
DISCUSSION
Reports by several authors have indicated that hematopoi-
etic growth factors play a role in the differentiation of neuronal
cells. In this study we focussed on obtaining a clonal population
of CNS progenitors in which one cytokine receptor (IL3R) was
expressed exogenously, thus generating a tool in which signal
transduction pathways and biological response activated by
cytokines in CNS progenitors could be studied.
In this study we have shown that physiologically expressed
TABLE I
IL3 effect on the incorporation of [3H]thymidine in IL3R-transfected
ST14A cells
The experiment was performed on cultures deprived of serum for 16
h prior to treatment. [3H]thymidine incorporation was measured after
24-h incubation in SFM in the absence (left columns) or presence (right
columns) of 2 ng/ml recombinant murine IL3. Radioactive thymidine
was added 6 h before collecting the cells. Each value is mean 6 S.D.;
n56. The data were repeatedly conformed in several experiments per-
formed over the last 2 years and on cells that were passaged several
times.
Clone 2IL3 1IL3a
ab14 256 6 91 514 6 13**
ab20 251 6 9 394 6 20**
ab28 181 6 24 249 6 18*
ab29 227 6 28 339 6 17**
b11 182 6 8 195 6 21
a19 193 6 13 191 6 15
a ** p,0.0001 and *p,0.001 over the respective control cultures by
Student’s t test.
FIG. 3. Effect of different doses of rmIL3 on ab14 cells. Tripli-
cate samples were incubated with 0.05, 0.2, 2, 10, and 50 ng/ml of IL3
in SFM. Each value is mean 6 S.D.; n 5 6. Data are expressed as
percentage versus control.
FIG. 4. Growth curve analysis on ab14 cells. At time zero, 0.3 3
105 cells were incubated with PBS 1 bovine serum albumin (open
circles) or with 2 ng/ml of rmIL3 (closed circles). At 24-h intervals after
addition of IL3, triplicate samples were trypsinized and counted using
a Coulter counter as described under “Experimental Procedures.” The
graphs indicate the absolute number of live cells found in the cultures
in the absence (solid line) or presence (broken line) of IL3. At each time
interval the number of cells found in the presence of IL3 was signifi-
cantly different from that in control cultures (p , 0.001–0.0001 by
Student’s t test). Values are expressed as mean 6 S.D., n 5 3. Data are
from one of four independent experiments giving the same growth
profile.
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Jak2 in embryonic CNS progenitors is phosphorylated on stim-
ulation of the exogenous IL3R (Fig. 5, B and C), ultimately
leading the stimulated cells to enter a new S phase (Fig. 4).
Furthermore, in our experimental system, we found that the
association of Jak2 with the exogenous b chain is largely ligand-
dependent (Fig. 5A). Although we focussed on the IL3R, it is
possible that other cytokines and cytokine receptors function-
ing through the Jak2 system also activate this pathway and
hence importantly contribute to the differentiation of the var-
ious cell types and functions of the developing central nervous
system.
It has been recently reported that, in the hematopoietic
system, Jak2 activation by IL3 leads to phosphorylation of a
transcription factor known as Stat5 (30). It was shown that
Stat5 mRNA is expressed in the brain (30).2 In this study we
provide additional evidence for the involvement of Stat5 in
CNS functions as we show that this transcription factor be-
comes phosphorylated on tyrosine following stimulation of the
CNS cells through the reconstituted IL3R.
Entry into a new S phase was demonstrated in all the cell
clones we isolated that expressed both subunits of the high
affinity IL3 receptor. This result suggests that the biological
effect observed is not linked to a particular integration of the
transgene into the host genome, but argue in favor of a possible
physiological role of the activated JAK/STAT pathway in CNS
cells.
The biological effect observed was further exploited in the
ab14 clone. In these cells the Kd of the receptor-ligand complex
was similar to that measured in hematopoietic cells, both being
in the picomolar range (28). In addition, we demonstrated that
in stimulated ab14 cells the incorporation of [3H]thymidine can
be partially blocked by an antibody recognizing the transfected
b receptor subunit. The absence of a complete blockade may be
due to the presence of a small population of activated receptors
on the cell membrane still stimulated by the agonist, perhaps
as a consequence of different affinities of the agonist and the
blocking antibody for the receptor complex. Growth curve anal-
ysis of stimulated ab14 cells revealed that a single addition of
IL3 was capable of sustaining cell division for several days
following stimuli. Furthermore, we found that, at each time
interval, the effect depended on the presence of the growth
factor and conditioned medium from ab14 cells did not elicit
any change in the incorporation of [3H]thymidine in parental
ST14A cells (not shown), indicating that the observed effect
was not due to molecules released into the culture medium
following stimulation with IL3.
We have also shown that the pattern of Jak1, Jak2, and Tyk2
expression in ST14A CNS progenitors is closely similar to that
found in vivo in the tissue from which ST14A cells were derived
(Fig. 1A). The absence of Jak1 in both the in vivo material and
in the immortalized progenitors seems to contrast with results
of Yang et al. (17) who reported the presence of the mRNA for
this protein in total brain from the E15 mouse. However, in
that report, protein expression was confirmed primarily in
sections from the developing retina or in adult tissue where
immunoreactive material was found confined to a few subpopu-
lations of cells.
We have demonstrated that CNS progenitors expressing
Jak2 and devoid of intrinsic responsiveness to specific cyto-
kines are stimulated to proliferate when a particular cytokine
receptor is provided experimentally. However, it could be ar-
gued that this biological effect might not be specifically driven
by the presence of an activated IL3R on the cell surface, but
that the transfected receptor is activating an endogenous pre-
determined program of cell division. Although this possibility
cannot be completely ruled out, other authors have shown that
immortalized cell lines generated following the methodology we
used to obtain the ST14A cells are capable of either prolifera-
tion in serum or differentiation upon stimulation of transfected
neurotrophin receptors (31). Data on the capability of ST14A
cells to differentiate are provided by intracerebral transplan-
tation experiments in which ST14A cells were shown to become
growth restricted (27) and to differentiate morphologically and
biochemically into neurons and glial cells (11).3 Furthermore,
the IL3R-expressing clone (ab14 cells) as well as parental
ST14A cells have been found to differentiate and to express
neuronal antigens when exposed in vitro to SFM conditions
(20).2 However, ab14 cells continue to divide in these same
conditions (absence of serum) when stimulated through the
IL3R, indicating that recruitment of specific cytoplasmic trans-
ducers actively triggers a program of cell division in CNS
progenitors that would otherwise differentiate.
The finding that this recently identified JAK/STAT pathway
3 C. Lundberg, submitted for publication.
FIG. 5. IL3-dependent Jak2 and Stat5 phosphorylation in ab14 cells. ab14 cells were starved in serum-free medium for 16 h and
stimulated with or without IL3 for 5 or 10 min. The lysates were immunoprecipitated with rat anti-AIC2A monoclonal antibody (A) or with 4G10
antiphosphotyrosine antibody (B and C). An aliquot was run on SDS-PAGE as described under “Experimental Procedures” and immunoblotted
with anti-Jak2 (A and B) or anti-Stat5 antibodies (C).
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is also present in CNS cells and is susceptible to activation,
indicates that the same intracellular machinery normally me-
diating cytokine signaling in hematopoietic cells can operate in
other tissues. Through a transient and localized expression of
cytokine receptors and of their ligands, activated JAK/STAT
proteins can constitute the effectors involved in important bi-
ological functions elicited by cytokines during the development
of the central nervous system.
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